Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Reductions in antibiotics achievable if guidelines on prescribing duration observed, says NICE

Substantial reductions in antibiotic exposure could be achieved by ensuring that the duration of prescriptions fall in line with national guidance, the National Institute of Health and Care Excellence (NICE) has said.

This recommendation follows the outcome of a large cross-sectional study, published in February 2019, which found that at least 80% of antibiotic treatments for upper respiratory tract indications, such as acute cough and bronchitis, exceeded the course length recommended by current guidelines.

NICE and Public Health England have jointly published antimicrobial prescribing guidelines for a range of common infection topics, which include recommendations on the choice, dosage and course length of antibiotics, if appropriate.

“The decision about whether to prescribe in these conditions can be complex and requires consideration of the individual’s risk factors,” said Tessa Lewis, a GP and chair of the NICE managing common infections advisory committee.

“However, the decision on what antibiotic course length to use for acute cough should be more straightforward.

“Guidance on length of treatment for cough was consistent for several years prior to 2013. The NICE guideline on antimicrobial stewardship reminds the prescriber to follow prescribing guidelines and use the shortest effective course, and that stewardship teams provide feedback and advice to prescribers who prescribe antimicrobials outside of local guidelines when it is not justified.”

The current goal in the UK is to reduce inappropriate antibiotic prescribing by 50% by 2020/2021.

The UK also has a 20-year vision and 5-year national action plan on antimicrobial resistance for 2019–2024.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206686

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.